pharmaceutical companies
Even with lawsuits and co-pay caps, will Insulin ever be affordable?
The sausage-making of how insulin is priced is not for the faint of heart. I’m a physician, not an economist. But the diagnosis seems plain as day: greed. Once we’ve allowed health care to be an economic entity like mobile phones, sports cars, and jewelry, all players with fingers in the pie will extract as much money from the process as the market will bear. More
Pharma in the Jungle
How to make pharmaceutical R&D worthy of James Bond-like drama. It’s not easy, but Anne Patchett gamely tries. An American drug company based in the dull stretches of Minnesota is racing to develop the holy grail of fertility drugs—a simple pill to allow women to get pregnant at any age. The stockholders are rubbing their palms rapaciously at the mere thought. More
